Amgen's NESP victory cuts out Johnson & Johnson.
Fürst
I
I
D004345:Drug Industry / Q000191:economics / Q000331:legislation & jurisprudence*; D004465:Economic Competition; D004920:Erythropoiesis / Q000187:drug effects*; D004921:Erythropoietin / Q000494:pharmacology; D014481:United States
D004921:Erythropoietin